Vascular endothelial growth factor at high plasma levels is associated with extranodal involvement in adult T cell leukemia patients

High pre-treatment serum level of vascul

High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer

✍ Petri Salven; Tarja Ruotsalainen; Karin Mattson; Heikki Joensuu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 68 KB 👁 2 views

Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis and vascular permeability. Increased serum VEGF concentrations (S-VEGF) have been found in patients with various types of human cancer, including cancer of the lung. However, the clinical and prognostic significance